These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3554658)

  • 21. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir.
    Prentice HG; Hann IM
    Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
    Saral R; Ambinder RF; Burns WH; Angelopulos CM; Griffin DE; Burke PJ; Lietman PS
    Ann Intern Med; 1983 Dec; 99(6):773-6. PubMed ID: 6359995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
    Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
    JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial.
    Wade JC; Newton B; McLaren C; Flournoy N; Keeney RE; Meyers JD
    Ann Intern Med; 1982 Mar; 96(3):265-9. PubMed ID: 7036816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection.
    Meyrick Thomas RH; Dodd HJ; Yeo JM; Kirby JD
    Br J Dermatol; 1985 Dec; 113(6):731-5. PubMed ID: 3913459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
    Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
    Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy.
    Tang IY; Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1758-60. PubMed ID: 2652575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
    Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Corey L; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Weller S; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
    Pediatrics; 2001 Aug; 108(2):230-8. PubMed ID: 11483782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study].
    Ehninger G; Vallbracht A; Schüch K; Kumbier I; Dopfer R; Schmidt H; Ostendorf P
    Klin Wochenschr; 1986 Jun; 64(12):570-4. PubMed ID: 2426515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.
    Ljungman P; Lönnqvist B; Ringdén O; Skinhöj P; Gahrton G
    Bone Marrow Transplant; 1989 Nov; 4(6):613-5. PubMed ID: 2684306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.
    Corey L; Benedetti J; Critchlow C; Mertz G; Douglas J; Fife K; Fahnlander A; Remington ML; Winter C; Dragavon J
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():79-88. PubMed ID: 6355054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC; Day LM; Crowley JJ; Meyers JD
    J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
    Wade JC; McLaren C; Meyers JD
    J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic studies against herpes infections in severely immunocompromised patients with acyclovir.
    Prentice HG; Hann IM
    J Infect; 1983 May; 6(1 Suppl):17-21. PubMed ID: 6350471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
    Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
    N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.
    Mitchell CD; Bean B; Gentry SR; Groth KE; Boen JR; Balfour HH
    Lancet; 1981 Jun; 1(8235):1389-92. PubMed ID: 6113352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.